Pregabalin CAS: 148553-50-8

CAS NO: 148553-50-8
Pregabalin
Chemical Name: Pregabalin
Molecular Formula: C8H17NO2
Formula Weight: 159.23
CAS No.: 148553-50-8
Description Review
Description

Pregabalin, also known by its brand name Lyrica, is a medication that is used to treat certain types of seizures, anxiety disorders, and neuropathic pain. It was first approved for medical use in the United States in 2004. Pregabalin has been found to be highly effective in treating a variety of conditions and is considered to be a safe and well-tolerated medication.

Chemical name: (S)-3-(aminomethyl)-5-methylhexanoic acid Molecular formula: C8H17NO2 Formula weight: 159.23 g/mol CAS No: 148553-50-8

Top ten keywords from Google and Synonyms:

  1. Lyrica
  2. Anxiety
  3. Neuropathic pain
  4. Seizures
  5. Gabapentinoid
  6. GABA analogue
  7. Anticonvulsant
  8. Controlled substance
  9. Prescription medication
  10. Nerve pain

Health benefits of this product: Pregabalin is primarily used to treat neuropathic pain caused by nerve damage, such as from diabetes or shingles. It can also be used to treat fibromyalgia, epilepsy, and generalized anxiety disorder. Pregabalin is a gabapentinoid, which means it works similarly to the drug gabapentin. Both drugs work by binding to calcium channels in the brain and reducing the release of neurotransmitters that signal pain and anxiety.

Potential effects: Pregabalin can have both positive and negative effects on the body. Its primary benefit is its ability to reduce neuropathic pain and anxiety, but it can also cause dizziness, drowsiness, and confusion. In rare cases, pregabalin can cause suicidal thoughts or behaviors.

Product mechanism: The exact mechanism of action for pregabalin is not fully understood, but it is believed to work by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This reduces the release of certain neurotransmitters, including glutamate, substance P, and noradrenaline, which are involved in pain signaling and anxiety.

Safety: Pregabalin is generally considered to be safe when taken as directed. However, it is classified as a controlled substance in many countries because it has the potential for abuse and addiction. It should not be taken by individuals with a history of drug or alcohol dependence. Pregabalin can also interact with other medications, so it is important to inform your doctor of any other medications you are taking before starting pregabalin.

Side effects: Common side effects of pregabalin include dizziness, drowsiness, dry mouth, headache, and blurred vision. More serious side effects, such as difficulty breathing or rash, are rare but can occur. Pregabalin may also increase the risk of suicidal thoughts or behavior in some individuals.

Dosing information: The recommended dose of pregabalin varies depending on the condition being treated. For neuropathic pain and fibromyalgia, the starting dose is usually 75 mg twice daily, with a maximum dose of 300 mg per day. For anxiety disorders, the starting dose is usually 75 mg twice daily, with a maximum dose of 600 mg per day. Pregabalin should always be taken as directed by a healthcare professional.

Conclusion: Pregabalin is a highly effective medication for treating certain types of seizures, anxiety disorders, and neuropathic pain. It works by reducing the release of neurotransmitters that signal pain and anxiety. While it is generally considered safe, it does have the potential for abuse and addiction and should be taken only as directed by a healthcare professional. The most common side effects of pregabalin include dizziness, drowsiness, and dry mouth, but more serious side effects are rare. If you are experiencing neuropathic pain, anxiety, or seizures, pregabalin may be an effective treatment option for you.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code